~~<i id='0B0EE873DF'><strike id='0B0EE873DF'><tt id='0B0EE873DF'><pre id='0B0EE873DF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：explore 2025-09-08 04:00:59 - browse：2223

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Wikipedia

focus

leisure time

hotspot

focus

AdobeWASHINGTON—DoctorsarestaringdownacuttotheirMedicarepaynextyear,andwhilethenewshasunitedtheminou

WSS

Laying a path for careers in science

Today's health inequities arise from racist U.S. history, say experts

Today's health inequities arise from racist U.S. history, say experts

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

A letter from the executive editor: STAT UnitedHealth investigation

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

focus

entertainment

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Beam, Prozac, "TechBio" and more

Affirmative action in medical school literally saved lives

Publishing genetic code of viruses could cause disaster

23andMe had bad news about my health. I wish a person had delivered it

Study fuels hope CAR

Peter Hotez and the public health issue of online harassment

Doctor of U.S. President Joe Biden says he is fit for duty

Cancer drug shortages should be causing more outrage

Children’s Hospital revives plan for pedestrian bridge

focus

Study fuels hope CAR

FDA reorg will put new emphasis on investigations, sources say

STAT Madness 2024: Meet the contenders

Type 2 diabetes prevention programs work at large scale: study

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Ohio still needs to do more to protect the right to abortion

leisure time

hotspot

focus

focus